MarketFriction

Hindustan Bio Sciences Ltd

BSE 532041 · Software Products
₹7.35 +0.14%
BSE close2026-10-01
Market cap₹7.21 Cr.

Price

Drag to pan, scroll or pinch to zoom. Ruler (or Shift + drag) measures a move.Dashed lines: 52 week high and low. Prices adjusted for splits and bonuses.

Financials

Standalone, Rs crore
Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales0.320.320.390.410.410.000.380.320.000.380.000.00
Expenses0.260.260.350.340.340.040.280.320.060.310.110.11
Operating Profit0.060.060.040.070.07-0.040.100.00-0.060.07-0.11-0.11
OPM %18.75%18.75%10.26%17.07%17.07%26.32%0.00%18.42%
Other Income0.010.010.000.010.010.000.010.010.010.020.000.00
Interest0.000.000.000.000.000.000.000.000.000.000.000.00
Depreciation0.000.000.000.000.000.000.000.000.000.010.000.00
Profit before tax0.070.070.040.080.08-0.040.110.01-0.050.08-0.11-0.11
Tax %0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Net Profit0.070.070.040.080.08-0.040.110.01-0.060.08-0.12-0.11
EPS in Rs0.070.070.040.080.08-0.040.110.01-0.060.08-0.12-0.11
Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales1.261.011.033.561.941.030.430.921.050.810.740.38
Expenses1.381.483.383.431.801.970.940.950.990.710.750.59
Operating Profit-0.12-0.47-2.350.130.14-0.94-0.51-0.030.060.10-0.01-0.21
OPM %-9.52%-46.53%-228.16%3.65%7.22%-91.26%-118.60%-3.26%5.71%12.35%-1.35%-55.26%
Other Income-1.920.000.090.000.000.000.000.000.000.00-0.050.03
Interest0.030.010.000.010.010.010.000.000.000.000.000.00
Depreciation0.010.010.010.010.010.010.000.010.010.000.020.01
Profit before tax-2.08-0.49-2.270.110.12-0.96-0.51-0.040.050.10-0.08-0.19
Tax %0.00%0.00%0.00%0.00%33.33%-2.08%0.00%0.00%0.00%0.00%0.00%
Net Profit-2.09-0.49-2.280.110.08-0.94-0.52-0.040.060.10-0.08-0.21
EPS in Rs-2.04-0.48-2.220.110.08-0.92-0.51-0.040.060.10-0.08-0.21
Dividend Payout %0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
10 Years5 Years3 YearsTTM1 YearLast Year
Compounded Sales Growth-5%-6%-7%-66%
Compounded Profit Growth6%15%8%-231%
Stock Price CAGR17%13%7%-13%
Return on Equity-22%-10%5%-3%
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital10.2510.2510.2510.2510.2510.2510.2510.252.052.052.052.05
Reserves-3.34-5.43-5.92-8.20-8.09-8.01-8.95-9.46-1.30-1.25-1.15-1.22
Borrowings0.970.941.301.573.372.601.862.172.462.562.512.35
Other Liabilities0.170.120.240.090.100.710.320.020.080.010.010.02
Total Liabilities8.055.885.873.715.635.553.482.983.293.373.423.20
Fixed Assets0.080.070.060.060.060.050.040.040.030.030.030.01
CWIP1.920.000.000.000.000.000.000.000.000.000.000.00
Investments0.000.000.000.000.000.000.000.000.000.000.000.00
Other Assets6.055.815.813.655.575.503.442.943.263.343.393.19
Total Assets8.055.885.873.715.635.553.482.983.293.373.423.20
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity-0.270.46-0.16-0.23-1.320.820.75-0.34-0.05-1.410.030.28
Cash from Investing Activity0.000.000.000.00-0.010.000.000.000.000.000.00-0.01
Cash from Financing Activity0.30-0.630.180.211.50-0.81-0.930.340.051.43-0.05-0.16
Net Cash Flow0.03-0.170.01-0.020.170.01-0.18-0.010.000.03-0.020.12
Free Cash Flow-0.270.46-0.16-0.23-1.330.820.75-0.34-0.05-1.410.030.27
CFO/OP22%-383%34%10%-1,015%600%-78%67%167%-2,350%30%-2,800%
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days155.73136.15169.85113.40171.22255.88219.71118.84178.53152.95198.2724.66
Inventory Days25.080.000.0051.2313.8995.460.000.000.000.000.000.00
Days Payable39.0144.827.58185.31
Cash Conversion Cycle141.80136.15169.85119.80177.54166.03219.71118.84178.53152.95198.2724.66
Working Capital Days111.93-63.73-191.53-170.1085.1086.55-148.83-500.81-226.14312.86441.60305.81
ROCE %-16.40%-1.91%-8.43%-49.08%2.62%2.51%-23.75%-16.67%-1.30%1.52%2.95%-0.91%
Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters12.19%12.19%12.19%12.19%12.19%12.19%12.19%12.19%12.19%12.19%12.19%12.19%
Public87.81%87.81%87.82%87.81%87.81%87.82%87.80%87.81%87.81%87.81%87.80%87.81%
No. of Shareholders9,25310,31510,92111,77911,61811,27611,24611,62011,40511,51611,53011,707

Fundamentals

Market Cap₹ 7.21 Cr.
Current Price₹ 7.03
Book Value₹ 0.81
ROCE-0.91 %
ROE-3.47 %
Dividend Yield0.00 %
Face Value₹ 2.00
Compounded Sales Growth (TTM)-66%
Compounded Profit Growth (TTM)-231%
Standalone figures.
Valuation
Market capRs 8 Cr
Enterprise valueRs 10 Cr
Price to book9.08x
Price to sales10.18x
EV / sales13.18x
Price to cash flow26.91x
Earnings yield-2.79%
P/E, 3-year average97.71x
P/B, 3-year average8.95x
P/E, 5-year average97.71x
P/B, 5-year average6.75x
Profitability
Operating margin (excl. other income)-1.35%
Operating margin (incl. other income)-8.11%
EBITDA margin-22.97%
Pre-tax margin-25.68%
Net profit margin-28.38%
ROE-9.25%
ROCE-2.43%
ROA-2.42%
ROE, 3-year average3.42%
ROCE, 3-year average0.68%
ROA, 3-year average0.78%
ROE, 5-year average-8.94%
ROCE, 5-year average-3.18%
ROA, 5-year average-3.01%
ROIC (approx.)-6.23%
Other income / net worth-6.02%
Growth
Sales growth (latest year)-8.64%
Profit growth (latest year)-180.00%
Sales CAGR, 3 years-7.00%
Sales CAGR, 5 years-6.40%
Profit growth YoY (latest quarter)-1200.00%
Per share
EPS (TTM)Rs -0.20
EPS (latest year)Rs -0.08
EPS (latest quarter)Rs -0.11
EPS, 3-year averageRs 0.03
EPS, 5-year averageRs -0.12
Book value per shareRs 0.81
Sales per shareRs 0.72
Cash flow per shareRs 0.27
Free cash flow per shareRs 0.26
Efficiency
Asset turnover0.23x
Fixed asset turnover74.00x
Debtor days25 days
Debtors turnover14.80x
Creditor days185 days
Cash conversion cycle25 days
Working capital days306 days
Leverage
Total debtRs 2 Cr
Cash and bankRs 0 Cr
Net debtRs 2 Cr
Debt to equity2.83x
Owners' fund to total sources25.94%
Debt to assets73.44%
Cash flow
Cash from Operating Activity (latest year)Rs 0 Cr
Cash from Investing Activity (latest year)Rs -0 Cr
Cash from Financing Activity (latest year)Rs -0 Cr
Net Cash Flow (latest year)Rs 0 Cr
Free cash flow (latest year)Rs 0 Cr
FCFE (approx.: FCF + change in debt)Rs 0 Cr
Sales to cash flow2.64x
Statement figures
Net sales (TTM)Rs 1 Cr
Net sales (latest year)Rs 1 Cr
Operating profit excl. other income (latest year)Rs -0 Cr
Operating profit (latest quarter)Rs -0 Cr
Other income (TTM)Rs -0 Cr
EBITDA (TTM)Rs -0 Cr
PBDT (TTM)Rs -0 Cr
Profit before tax (TTM)Rs -0 Cr
Net profit (TTM)Rs -0 Cr
Net profit (latest year)Rs -0 Cr
Net profit (latest quarter)Rs -0 Cr
Depreciation (TTM)Rs 0 Cr
Cost of goods sold (latest year)Rs 0 Cr
Total expenditure (latest year)Rs 1 Cr
Total income (latest year)Rs 1 Cr
Share capitalRs 2 Cr
ReservesRs -1 Cr
Shareholders' fundsRs 1 Cr
Total assetsRs 3 Cr
Net blockRs 0 Cr
ReceivablesRs 0 Cr
Other liabilitiesRs 0 Cr
Shares outstanding (crore)1.03
Ownership
Promoter holding12.19% (+0.00 in a year)
Computed by MarketFriction from the standalone statements. Returns use average balances.
P/B 9.08 is at the 73th percentile (median 3.78).
Monthly. Market cap from split-adjusted price; profit and book value as reported by that month. A low percentile means cheap versus its own history, not cheap versus peers.
Period532041Nifty 50Difference
1 week-1.3%-2.8% +1.4 pts
1 month-7.4%-6.8% -0.6 pts
3 months+0.7%-7.6% +8.3 pts
3 years+27.8%+14.2% +13.7 pts
5 years+106.5%+27.9% +78.6 pts

Red flags

F-score 3 of 8
explainWeak cash conversion Cash from operations was -1375% of net profit over the last 3 years
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.

Latest quarter

Jun 2026
Sales ₹0 Cr -100.0% vs Jun 2025. Net loss ₹0 Cr.

Activity

Compare
CompanyMcap (Cr)P/EROCE
Oracle Financial Services Software Ltd90,63826.645.3 %
Tanla Platforms Ltd6,50812.226.3 %
C.E. Info Systems Ltd4,63533.619.1 %
Capillary Technologies India Ltd4,51688.23.42 %
TechNVision Ventures Ltd2,44781613.6 %
Mobavenue AI Tech Ltd2,33966.871.6 %
Ramco Systems Ltd2,07833.019.7 %
Blue Cloud Softech Solutions Ltd1,86729.214.2 %
Nucleus Software Exports Ltd1,71715.016.8 %
Subex Ltd1,14635.412.8 %
Unicommerce eSolutions Ltd92643.621.1 %
Quick Heal Technologies Ltd794-5.97 %
IRIS Regtech Solutions Ltd47336.910.6 %
Sotefin Bharat Ltd47227.231.2 %
Ace Software Exports Ltd36886.15.82 %
No bulk or block deals on record.
No corporate actions on record.
No announcements in our files yet.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Not on any NSE surveillance list in the latest file.

Quick answers

What is the market cap of Hindustan Bio Sciences Ltd?

Hindustan Bio Sciences Ltd (532041) has a market capitalisation of Rs 7.21 Cr. at the 2026-10-01 close.

What were Hindustan Bio Sciences Ltd's latest quarterly results?

In the Jun 2026 quarter, Hindustan Bio Sciences Ltd sales was Rs 0 Cr (-100.0% vs Jun 2025) with a net loss of Rs 0 Cr.

Data: NSE and BSE daily reports, company filings. Numbers only, not investment advice, not a SEBI-registered research service.AboutMethodologyFAQResearchContactTermsPrivacyDisclaimerUpdated 2026-10-03